AVXL
Price:
$4.45
Market Cap:
$397.60M
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patients with Rett syndrome; Phase II clinical trial for the treatment of Parkinson's disease; and preclinical clinical trials to treat epilepsy, infantile spasms, Fragile X syndrome, Angelman syndrome, multiple sclerosis, and tuberous sclerosis complex. The company's drug candidate also comprises ANAVEX 3-71, which is in Phase I clinical trial for the trea...[Read more]
Industry
Biotechnology
IPO Date
2006-08-02
Stock Exchange
NASDAQ
Ticker
AVXL
According to Anavex Life Sciences Corp.’s latest financial reports and current stock price. The company's current Current Ratio is 13.41. This represents a change of 39.47% compared to the average of 9.61 of the last 4 quarters.
The mean historical Current Ratio of Anavex Life Sciences Corp. over the last ten years is 9.81. The current 13.41 Current Ratio has changed 13.57% with respect to the historical average. Over the past ten years (40 quarters), AVXL's Current Ratio was at its highest in in the March 2022 quarter at 19.86. The Current Ratio was at its lowest in in the September 2016 quarter at 2.96.
Average
9.81
Median
8.31
Minimum
2.96
Maximum
20.30
Discovering the peaks and valleys of Anavex Life Sciences Corp. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 216.54%
Maximum Annual Current Ratio = 20.30
Minimum Annual Increase = -49.08%
Minimum Annual Current Ratio = 2.96
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 20.30 | 129.12% |
| 2024 | 8.86 | -28.08% |
| 2023 | 12.32 | -17.62% |
| 2022 | 14.95 | -0.10% |
| 2021 | 14.97 | 216.54% |
| 2020 | 4.73 | -5.93% |
| 2019 | 5.03 | -19.73% |
| 2018 | 6.26 | -19.23% |
| 2017 | 7.75 | 161.83% |
| 2016 | 2.96 | -49.08% |
The current Current Ratio of Anavex Life Sciences Corp. (AVXL) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
13.82
5-year avg
14.28
10-year avg
9.81
Anavex Life Sciences Corp.’s Current Ratio is greater than Erasca, Inc. (11.04), greater than MeiraGTx Holdings plc (0.22), less than MoonLake Immunotherapeutics (16.65), greater than Arvinas, Inc. (5.70), less than MBX Biosciences, Inc. Common Stock (32.95), less than Astria Therapeutics, Inc. (14.89), greater than CytomX Therapeutics, Inc. (3.64), greater than Valneva SE (2.27), greater than REGENXBIO Inc. (2.66), greater than Absci Corporation (4.39),
| Company | Current Ratio | Market cap |
|---|---|---|
| 11.04 | $905.04M | |
| 0.22 | $692.22M | |
| 16.65 | $955.18M | |
| 5.70 | $911.69M | |
| 32.95 | $1.03B | |
| 14.89 | $748.95M | |
| 3.64 | $691.03M | |
| 2.27 | $742.49M | |
| 2.66 | $657.04M | |
| 4.39 | $560.88M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Anavex Life Sciences Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Anavex Life Sciences Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Anavex Life Sciences Corp.'s Current Ratio?
How is the Current Ratio calculated for Anavex Life Sciences Corp. (AVXL)?
What is the highest Current Ratio for Anavex Life Sciences Corp. (AVXL)?
What is the 3-year average Current Ratio for Anavex Life Sciences Corp. (AVXL)?
What is the 5-year average Current Ratio for Anavex Life Sciences Corp. (AVXL)?
How does the current Current Ratio for Anavex Life Sciences Corp. (AVXL) compare to its historical average?